glp-1 drugs impact on energy levels The Multi-Sector Impacts of GLP-1RA American drugmakers pushed GLP1 therapies
Description
Dual agonist: GLP-1 plus GIP: Tirzapeptide is a combination of GLP-1 RA and a GIP agonist that is FDA-approved for weight loss
2023 Accessed March 9, 2023
Biological characteristics of GLP-1 In the 1980s, a new glucagon-like peptide, produced from proglucagon cleavage, was discovered to stimulate insulin secretion (86)
Hill CJ, Fogarty DG
doi: 10.1210/jc.2002-021479 [DOI] [PubMed] [Google Scholar] 101
doi: 10.1016/j.mce.2021.111529 [DOI] [PubMed] [Google Scholar] 149
